Type 1 Diabetes Mellitus

Type 1 diabetes mellitus is a chronic disease in which autoimmune destruction of the insulin-producing beta cells of the pancreas leaves the body unable to make insulin, causing lifelong dependence on exogenous insulin to control blood glucose. It typically presents in childhood or young adulthood but can arise at any age.

Definition

Type 1 diabetes mellitus is a form of diabetes caused by immune-mediated destruction of pancreatic beta cells leading to absolute insulin deficiency and a lifelong requirement for insulin replacement.

Scope

This topic covers the autoimmune pathogenesis, clinical presentation, and diagnostic features of type 1 diabetes, and its place among the diabetes categories. It frames the disease as a reference clinical entity for understanding mechanism and classification; it is not a source of dosing or individualized management advice.

Core questions

• What immune process destroys the beta cells in type 1 diabetes?
• How does absolute insulin deficiency present clinically?
• How is type 1 diabetes distinguished from other forms of diabetes?
• Why does glycaemic control influence long-term complication risk?

Key concepts

• Autoimmune beta-cell destruction
• Absolute insulin deficiency
• Islet autoantibodies
• Genetic susceptibility (HLA)
• Diabetic ketoacidosis as a presenting feature
• Insulin dependence

Mechanisms

Type 1 diabetes results from a T-cell-mediated autoimmune attack on the insulin-secreting beta cells of the pancreatic islets, often marked by circulating islet autoantibodies that can precede clinical disease. As beta-cell mass falls, insulin secretion declines until the body can no longer regulate glucose, producing hyperglycaemia and, without insulin, a tendency to ketoacidosis. Susceptibility is strongly influenced by genetic factors, particularly HLA haplotypes, with environmental triggers thought to contribute to disease onset. Because insulin is essentially absent, the condition requires insulin replacement to sustain metabolism.

Clinical relevance

Type 1 diabetes is the principal cause of insulin-requiring diabetes in young people and a model for autoimmune endocrine disease; its long-term outcomes are tightly linked to glycaemic control. This entry describes mechanism, presentation, and classification for reference and does not provide insulin regimens or individualized treatment guidance.

Epidemiology

Type 1 diabetes accounts for a minority of all diabetes — on the order of five to ten percent of cases — but is the predominant form in children and adolescents, with incidence varying substantially by geography and rising in many populations. Onset peaks in childhood and puberty, though a meaningful share of cases present in adulthood.

Evidence & guidelines

The Diabetes Control and Complications Trial established that intensive glycaemic control reduces the development and progression of microvascular complications in type 1 diabetes, a finding that reshaped management goals. Classification and diagnostic criteria are maintained in the American Diabetes Association Standards of Care.

History

Type 1 diabetes was historically termed insulin-dependent or juvenile-onset diabetes, reflecting its insulin requirement and typical age of onset. Its recognition as an autoimmune disorder and the landmark Diabetes Control and Complications Trial in 1993 — which linked tight glucose control to fewer complications — are central milestones in its modern understanding.

Seminal works

• atkinson-2014
• dcct-1993

Frequently asked questions

What causes type 1 diabetes?

It is caused by an autoimmune process that destroys the insulin-producing beta cells of the pancreas, leaving the body unable to make insulin.

How does type 1 diabetes differ from type 2?

Type 1 results from autoimmune beta-cell destruction and absolute insulin deficiency requiring insulin replacement, whereas type 2 arises mainly from insulin resistance with relative insulin insufficiency.